Eluvia DES for the Patients with Femoropopliteal Artery Lesions.

This study is tracking outcomes in patients with blocked arteries in the upper leg (femoropopliteal artery) who are treated with the Eluvia drug-eluting stent — a special stent that slowly releases medication to keep the artery open. Researchers want to see how well patients do after this procedure over time. You may be eligible if: - You have peripheral artery disease (Rutherford Stage 2 to 5) - You have at least 90% blockage or complete occlusion of the femoropopliteal artery - The Eluvia stent is being used to treat your blockage - You agree to participate and sign the informed consent form You may NOT be eligible if: - Your life expectancy is less than 1 year - You have severe infection, gangrene, or tissue loss beyond the toes that may require major amputation regardless of treatment - You or your family are unwilling to join the study or have difficulty communicating for quality of life assessment - You have in-stent restenosis (re-blockage inside a prior stent) of the femoropopliteal artery - You have acute arterial blood clot (thrombosis) Talk to your doctor to see if this trial is right for you.